The natural history of chronic hepatitis B

Journal of Viral Hepatitis

Volumn 14, Issue SUPPL. 1, 2007, Pages 6-10

  Lai, C L ^a,b   Yuen, M F ^b  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

ALT; Cirrhosis; HBeAg serconversion; HBV DNA; Hepatocellular carcinoma

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADOLESCENCE; ADULTHOOD; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASCITES; ASIAN; BACTERIAL PERITONITIS; BIRTH; BRAIN DISEASE; CAUCASIAN; CONFERENCE PAPER; DISEASE COURSE; HEPATITIS B; HETEROZYGOTE DETECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; LIVER CARCINOMA; LIVER CIRRHOSIS; PRIORITY JOURNAL; SEROCONVERSION; VIRUS REPLICATION;

AGE FACTORS; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS;

EID: 35448983168     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2007.00909.x     Document Type: Conference Paper

References (28)

1. Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet 2003 362: 2089 2094.
2. Beasley RP, Hwang LY. Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis 1983 147: 185 190.
3. Lin HJ, Lai CL, Lau JY, Chung HT, Lauder IJ, Fong MW. Evidence for intrafamilial transmission of hepatitis B virus from sequence analysis of mutant HBV DNAs in two Chinese families. Lancet 1990 336: 208 212.
4. World Health Organization. WHO World Health Report 1996: Fighting Disease, Fostering Development. Geneva: World Health Organization, 1996.
5. Hyams KC. Risk of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995 20: 992 1000.
6. Di Bisceglie AM, Waggoner JG, Hoofnagle JH. Hepatitis B virus deoxyribonucleic acid in liver of chronic carriers. Correlation with serum markers and changes associated with loss of hepatitis B e antigen after antiviral therapy. Gastroenterology 1987 93: 1236 1241.
7. Hoofnagle JH, Shafritz DA, Popper H. Chronic type B hepatitis and the "healthy" HBsAg carrier state. Hepatology 1987 7: 758 763.
8. Manno M, Camma C, Schepis F et al. Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years. Gastroenterology 2004 127: 756 763.
9. Niederau C, Heintges T, Lange S et al. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 1996 334: 1422 1427.
10. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 1981 2: 1129 1133.
11. Beasley RP, Hwang LY. Hepatocellular carcinoma and hepatitis B virus. Semin Liver Dis 1984 4: 113 121.
12. Beasley RP. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma - epidemiologic considerations. Hepatology 1982 2: 21S 26S.
13. Gunther S, Fischer L, Pult I, Sterneck M, Will H. Naturally occurring variants of hepatitis B virus. Adv Virus Res 1999 52: 25 137.
14. Ballard AL, Boxall EH. Epidemiology of precore mutants of hepatitis B in the United Kingdom. J Med Virol 2000 62: 463 470.
15. Yuen MF, Erwin S, Yuan HJ et al. Relationship between the development of precore and core promoter mutations and hepatitis B e antigen seroconversion in patients with chronic hepatitis B virus. J Infect Dis 2002 186: 1335 1338.
16. Yuan HJ, Yuen MF, Wong DKH, Sablon E, Lai CL. The relationship between HBV-DNA levels and cirrhosis-related complications in Chinese with chronic hepatitis B. J Viral Hepat 2005 12: 373 379.
17. Yang HI, Lu SN, Liaw YF et al. Taiwan Community-Based Cancer Screening Project Group. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002 347: 168 174.
18. Liaw YF, Tai DI, Chu CM, Chen TJ. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology 1988 8: 493 496.
19. Yuen MF, Yuan HJ, Wong DK et al. Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications. Gut 2005 54: 1610 1614.
20. Jardi R, Rodriguez F, Buti M et al. Mutations in the basic core promoter region of hepatitis B virus. Relationship with precore variants and HBV genotypes in a Spanish population of HBV carriers. J Hepatol 2004 40: 507 514.
21. Chan HLY, Leung NWY, Hussain M, Wong ML, Lok ASF. Hepatitis B e antigen-negative chronic hepatitis b in Hong Kong. Hepatology 2000 31: 763 768.
22. Yuen MF, Sablon E, Yuan HJ et al. Relationship between the development of precore and core promoter mutations and hepatitis B e antigen seroconversion in patients with chronic hepatitis B virus. J Infec Dis 2002 186: 1335 1338.
23. Yuen MF, Tanaka Y, Mizokami M et al. Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study. Carcinogenesis 2004 25: 153 1598.
24. Liu CJ, Chen BF, Chen PJ et al. Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study. J Infect Dis 2006 194: 594 599.
25. Chen CJ, Yang HI, Su J et al. REVEAL-HBV Study Group. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006 295: 65 73.
26. Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ and The Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer-In HBV (the REVEAL-HBV) Study Group. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006 130: 678 686.
27. Kim HC, Nam CM, Jee SH, Han KH, Oh DK, Suh I. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ 2004 328: 983.
28. Alberti A. Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levels. J Hepatol 2005 42: 266 274.